This brand name is authorized in France, Ireland, Japan, Poland
The drug MONOVER contains one active pharmaceutical ingredient (API):
1
Ferric derisomaltose
UNII AHU547PI9H - FERRIC DERISOMALTOSE
|
Ferric derisomaltose is a complex of iron (III) hydroxide and derisomaltose, an iron carbohydrate oligosaccharide that releases iron. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. It is used for the treatment of iron deficiency anemia (IDA) in adult patients. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
MONOVER Solution for injection / infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B03AC | Iron trivalent, parenteral preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FR | Base de données publique des médicaments | Identifier(s): 60717355 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3222405A1026, 3222405A2022 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100225428 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.